CD163 and breast cancer: Moreover, the CD68+CD163+-CLS has been reported to exist in adipose tissue around BC lesions, and a high level of CD163+ macrophages (tumor-associated macrophages [TAMs]) was linked to shorter DFS (disease-free survival) in node-negative BC patients (P = 0.033) [24].